- call +1-201-465-4211
- email sales@mrinsights.biz
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
Scope of the Report:
In the last several years, global market of Paclitaxel developed rapidly, with an average growth rate of 12.3%. In 2017, global revenue of Paclitaxel is nearly 80 M USD; the actual production is about 2600 Kg.
The classification of Paclitaxel includes Natural Paclitaxel API and Semi-Synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 is about 31.3%, and the proportion is decreasing trend from 2012 to 2017.
The worldwide market for Paclitaxel is expected to grow at a CAGR of roughly 9.0% over the next five years, will reach 140 million US$ in 2024, from 90 million US$ in 2019, according to a new study.
This report focuses on the Paclitaxel in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Market Segment by Applications, can be divided into
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Paclitaxel product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Paclitaxel, with price, sales, revenue and global market share of Paclitaxel in 2017 and 2018.
Chapter 3, the Paclitaxel competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Paclitaxel breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Paclitaxel market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Paclitaxel sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Paclitaxel Introduction
1.2 Market Analysis by Type
1.2.1 Natural Paclitaxel API
1.2.2 Semi-synthetic Paclitaxel API
1.3 Market Analysis by Applications
1.3.1 Ovarian Cancer
1.3.2 Cervical Cancer
1.3.3 Breast Cancer
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Phyton
2.1.1 Business Overview
2.1.2 Paclitaxel Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Phyton Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 ScinoPharm
2.2.1 Business Overview
2.2.2 Paclitaxel Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 ScinoPharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novasep
2.3.1 Business Overview
2.3.2 Paclitaxel Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novasep Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Samyang
2.4.1 Business Overview
2.4.2 Paclitaxel Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Samyang Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Polymed
2.5.1 Business Overview
2.5.2 Paclitaxel Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Polymed Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 TAPI (Teva)
2.6.1 Business Overview
2.6.2 Paclitaxel Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 TAPI (Teva) Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Fresenius-kabi
2.7.1 Business Overview
2.7.2 Paclitaxel Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Fresenius-kabi Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Huiang biopharma
2.8.1 Business Overview
2.8.2 Paclitaxel Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Huiang biopharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Southpharma
2.9.1 Business Overview
2.9.2 Paclitaxel Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Southpharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Yunnan Hande
2.10.1 Business Overview
2.10.2 Paclitaxel Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Yunnan Hande Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Hainan Yew Pharm
2.11.1 Business Overview
2.11.2 Paclitaxel Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Hainan Yew Pharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Jiangsu Yew Biotechnology
2.12.1 Business Overview
2.12.2 Paclitaxel Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Paclitaxel Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Paclitaxel Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Paclitaxel Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Paclitaxel Manufacturer Market Share in 2018
3.3.2 Top 6 Paclitaxel Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Paclitaxel Market Analysis by Regions
4.1 Global Paclitaxel Sales, Revenue and Market Share by Regions
4.1.1 Global Paclitaxel Sales and Market Share by Regions (2014-2019)
4.1.2 Global Paclitaxel Revenue and Market Share by Regions (2014-2019)
4.2 North America Paclitaxel Sales and Growth Rate (2014-2019)
4.3 Europe Paclitaxel Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Paclitaxel Sales and Growth Rate (2014-2019)
4.5 South America Paclitaxel Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Paclitaxel Sales and Growth Rate (2014-2019)
5 North America Paclitaxel by Country
5.1 North America Paclitaxel Sales, Revenue and Market Share by Country
5.1.1 North America Paclitaxel Sales and Market Share by Country (2014-2019)
5.1.2 North America Paclitaxel Revenue and Market Share by Country (2014-2019)
5.2 United States Paclitaxel Sales and Growth Rate (2014-2019)
5.3 Canada Paclitaxel Sales and Growth Rate (2014-2019)
5.4 Mexico Paclitaxel Sales and Growth Rate (2014-2019)
6 Europe Paclitaxel by Country
6.1 Europe Paclitaxel Sales, Revenue and Market Share by Country
6.1.1 Europe Paclitaxel Sales and Market Share by Country (2014-2019)
6.1.2 Europe Paclitaxel Revenue and Market Share by Country (2014-2019)
6.2 Germany Paclitaxel Sales and Growth Rate (2014-2019)
6.3 UK Paclitaxel Sales and Growth Rate (2014-2019)
6.4 France Paclitaxel Sales and Growth Rate (2014-2019)
6.5 Russia Paclitaxel Sales and Growth Rate (2014-2019)
6.6 Italy Paclitaxel Sales and Growth Rate (2014-2019)
7 Asia-Pacific Paclitaxel by Country
7.1 Asia-Pacific Paclitaxel Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Paclitaxel Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Paclitaxel Revenue and Market Share by Country (2014-2019)
7.2 China Paclitaxel Sales and Growth Rate (2014-2019)
7.3 Japan Paclitaxel Sales and Growth Rate (2014-2019)
7.4 Korea Paclitaxel Sales and Growth Rate (2014-2019)
7.5 India Paclitaxel Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Paclitaxel Sales and Growth Rate (2014-2019)
8 South America Paclitaxel by Country
8.1 South America Paclitaxel Sales, Revenue and Market Share by Country
8.1.1 South America Paclitaxel Sales and Market Share by Country (2014-2019)
8.1.2 South America Paclitaxel Revenue and Market Share by Country (2014-2019)
8.2 Brazil Paclitaxel Sales and Growth Rate (2014-2019)
8.3 Argentina Paclitaxel Sales and Growth Rate (2014-2019)
8.4 Colombia Paclitaxel Sales and Growth Rate (2014-2019)
9 Middle East and Africa Paclitaxel by Countries
9.1 Middle East and Africa Paclitaxel Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Paclitaxel Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Paclitaxel Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Paclitaxel Sales and Growth Rate (2014-2019)
9.3 Turkey Paclitaxel Sales and Growth Rate (2014-2019)
9.4 Egypt Paclitaxel Sales and Growth Rate (2014-2019)
9.5 Nigeria Paclitaxel Sales and Growth Rate (2014-2019)
9.6 South Africa Paclitaxel Sales and Growth Rate (2014-2019)
10 Global Paclitaxel Market Segment by Type
10.1 Global Paclitaxel Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Paclitaxel Sales and Market Share by Type (2014-2019)
10.1.2 Global Paclitaxel Revenue and Market Share by Type (2014-2019)
10.2 Natural Paclitaxel API Sales Growth and Price
10.2.1 Global Natural Paclitaxel API Sales Growth (2014-2019)
10.2.2 Global Natural Paclitaxel API Price (2014-2019)
10.3 Semi-synthetic Paclitaxel API Sales Growth and Price
10.3.1 Global Semi-synthetic Paclitaxel API Sales Growth (2014-2019)
10.3.2 Global Semi-synthetic Paclitaxel API Price (2014-2019)
11 Global Paclitaxel Market Segment by Application
11.1 Global Paclitaxel Sales Market Share by Application (2014-2019)
11.2 Ovarian Cancer Sales Growth (2014-2019)
11.3 Cervical Cancer Sales Growth (2014-2019)
11.4 Breast Cancer Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Paclitaxel Market Forecast (2019-2024)
12.1 Global Paclitaxel Sales, Revenue and Growth Rate (2019-2024)
12.2 Paclitaxel Market Forecast by Regions (2019-2024)
12.2.1 North America Paclitaxel Market Forecast (2019-2024)
12.2.2 Europe Paclitaxel Market Forecast (2019-2024)
12.2.3 Asia-Pacific Paclitaxel Market Forecast (2019-2024)
12.2.4 South America Paclitaxel Market Forecast (2019-2024)
12.2.5 Middle East and Africa Paclitaxel Market Forecast (2019-2024)
12.3 Paclitaxel Market Forecast by Type (2019-2024)
12.3.1 Global Paclitaxel Sales Forecast by Type (2019-2024)
12.3.2 Global Paclitaxel Market Share Forecast by Type (2019-2024)
12.4 Paclitaxel Market Forecast by Application (2019-2024)
12.4.1 Global Paclitaxel Sales Forecast by Application (2019-2024)
12.4.2 Global Paclitaxel Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Paclitaxel Picture
Table Product Specifications of Paclitaxel
Figure Global Sales Market Share of Paclitaxel by Types in 2018
Table Paclitaxel Types for
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
